In drug manufacturing, aseptic filling is the crucial final step in advancing biologics candidates into the clinic. Whether drug manufacturers outsource the process ...

Aseptic B/F/S technology integrates blow molding, sterile filling and hermetic sealing in one continuous operation to produce aseptically manufactured pharmaceutical liquid products. Unique to aseptic ...

Aseptic filling—the final step before packaging parenteral small molecule and biotherapeutic drugs—represents one of the most technologically innovative and dynamic areas of downstream operations.

Leveraging automation advancements can help improve efficiency in aseptic processing and speed up commercialization of critical drug products. Chronic illnesses or non-communicable diseases that ...

Blow-fill-seal (BFS) equipment has been widely used for many years in aseptic fill/finish of small-molecule and biologic liquid formulations, including nebulizer solutions for respiratory delivery and ...

Blow-fill-seal (BFS) provides a sterile solution for aseptic technology by reducing human intervention in the fill/finish process that is expanding very fast and consider to be an advanced aseptic ...

Promising daily monitoring of plant workers' aseptic procedures was not enough to satisfy the FDA that Bristol-Myers Squibb has the persistent problem resolved. "Please provide more information on the ...

Aseptic formats are in high demand due to consumer preferences trending towards healthy options, fuelling investment in packaging and filling technologies. Product development in the beverage sector ...